Kenneth B. Kassler-Taub
SVP, Regulatory & QA, Lexicon Pharmaceuticals.
Companies
- Lexicon PharmaceuticalsSVP, Regulatory & QA Oct 1, 2021 to Feb 29, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lexicon Pharmaceuticals LXRX162,672 shares2$254.6K at $1.56Feb 28, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 28, 2024Shares withheld for tax 24,353 shares at $2.62 of Lexicon Pharmaceuticals2
- Feb 28, 2024Exercised options 32,757 shares of Lexicon Pharmaceuticals2
- Feb 28, 2024Exercised options 27,556 shares of Lexicon Pharmaceuticals2
- Feb 28, 2024Exercised options 7,087 shares of Lexicon Pharmaceuticals2
- Feb 28, 2023Shares withheld for tax 19,118 shares at $2.17 of Lexicon Pharmaceuticals3
- Feb 28, 2023Exercised options 27,557 shares of Lexicon Pharmaceuticals3
- Feb 28, 2023Exercised options 7,086 shares of Lexicon Pharmaceuticals3
- Feb 28, 2023Exercised options 18,243 shares of Lexicon Pharmaceuticals3
- Feb 28, 2022Shares withheld for tax 13,241 shares at $2.85 of Lexicon Pharmaceuticals4
- Feb 28, 2022Exercised options 7,087 shares of Lexicon Pharmaceuticals4
- Feb 28, 2022Exercised options 18,244 shares of Lexicon Pharmaceuticals4
- Feb 28, 2022Exercised options 11,297 shares of Lexicon Pharmaceuticals4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 1, 2023
- 4SEC EDGARForm 4 filed Feb 28, 2022